Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...
Michael Lauer, deputy director of the National Institutes of Health’s extramural research, will leave the agency at the end ...
The National Institutes of Health’s indirect funding cap could halt studies and limit researchers’ ability to find cures for ...
The fight unfolding over the Trump administration's sudden limit on NIH grant funding could slash budgets for Washington's ...
A federal judge temporarily halted the National Institures for Health cuts after 22 states sued President Trump's ...
Ruling on a lawsuit filed by 22 states, a federal judge has temporarily blocked the National Institutes of Health plan to cap ...
The order was temporarily blocked after Massachusetts and 21 other states filed a lawsuit opposing the NIH funding cuts.
“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...
These actions could postpone NIH-funded clinical trials and create cash flow issues for domestic biotech companies.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results